Simplify Your Move From A Vial To A Prefilled Syringe: Lifecycle Planning For Containment And Delivery Of Biologics Drug Products

By Abigail Hisler, Strategic Marketing Director of Biologics

Biologics are revolutionizing healthcare by offering a wider range of treatments and improving patient results. The constant flow of new, approved biologics reflects ongoing advancements in medicine, with even more promising discoveries on the horizon. Keeping up with ever-changing regulations and increasing scrutiny can be difficult. Despite existing regulations, guidance documents, and compendia, there's no single approach to qualifying your packaging system.

Limiting the number of materials your drug interacts with throughout its lifecycle can provide long-term benefits. These benefits include a smoother transition to combination products, faster regulatory approvals, and lower risks associated with packaging development for self-administered systems.

NovaPure® components are designed to offer the market superior quality, performance, and risk reduction. This brand encompasses stoppers, plungers, and cartridge plungers made with a 4023/50 formulation and FluroTec film. NovaPure® can support your drug's launch in a vial and future launches in prefilled syringes or autoinjectors.

Learn more about current trends in the biologics market that could influence your drug product's lifecycle strategies. Discover steps to take early in development regarding drug packaging to ensure future success.